Vildagliptin/Metformin SanoSwiss 50 mg/850 mg apvalkotās tabletes Латвия - латышский - Zāļu valsts aģentūra

vildagliptin/metformin sanoswiss 50 mg/850 mg apvalkotās tabletes

sanoswiss uab, lithuania - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Vildagliptin/Metformin SanoSwiss 50 mg/1000 mg apvalkotās tabletes Латвия - латышский - Zāļu valsts aģentūra

vildagliptin/metformin sanoswiss 50 mg/1000 mg apvalkotās tabletes

sanoswiss uab, lithuania - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Asigefort 50 mg/850 mg apvalkotās tabletes Латвия - латышский - Zāļu valsts aģentūra

asigefort 50 mg/850 mg apvalkotās tabletes

tad pharma gmbh, germany - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Asigefort 50 mg/1000 mg apvalkotās tabletes Латвия - латышский - Zāļu valsts aģentūra

asigefort 50 mg/1000 mg apvalkotās tabletes

tad pharma gmbh, germany - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Jivolar 50 mg/850 mg apvalkotās tabletes Латвия - латышский - Zāļu valsts aģentūra

jivolar 50 mg/850 mg apvalkotās tabletes

medochemie ltd., cyprus - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Jivolar 50 mg/1000 mg apvalkotās tabletes Латвия - латышский - Zāļu valsts aģentūra

jivolar 50 mg/1000 mg apvalkotās tabletes

medochemie ltd., cyprus - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Sitagliptin/Metformin Billev 50 mg/850 mg apvalkotās tabletes Латвия - латышский - Zāļu valsts aģentūra

sitagliptin/metformin billev 50 mg/850 mg apvalkotās tabletes

billev farmacija vzhod d.o.o., slovenia - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Sitagliptin/Metformin Billev 50 mg/1000 mg apvalkotās tabletes Латвия - латышский - Zāļu valsts aģentūra

sitagliptin/metformin billev 50 mg/1000 mg apvalkotās tabletes

billev farmacija vzhod d.o.o., slovenia - sitagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Sitagliptin / Metformin hydrochloride Sun Европейский союз - латышский - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - cukura diabēts, 2. tips - cukura diabēts - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , triple kombinēto terapiju), kā palīglīdzekli, lai diētu un vingrošanu pacientiem nepietiekami kontrolē par to maksimālā pieļaujama devu metformīns un sulfonilurīnvielas pamata. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Retsevmo Европейский союз - латышский - EMA (European Medicines Agency)

retsevmo

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastiski līdzekļi - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.